严重精神疾病患者的长期死亡率趋势以及 COVID-19、种族和其他慢性精神健康合并症的影响:一项回顾性队列研究。

IF 5.9 2区 医学 Q1 PSYCHIATRY Psychological Medicine Pub Date : 2024-10-21 DOI:10.1017/S0033291724001843
Jayati Das-Munshi, Ioannis Bakolis, Laia Bécares, Hannah K Dasch, Jacqui Dyer, Matthew Hotopf, Rosie Hildersley, Josephine Ocloo, Robert Stewart, Ruth Stuart, Alex Dregan
{"title":"严重精神疾病患者的长期死亡率趋势以及 COVID-19、种族和其他慢性精神健康合并症的影响:一项回顾性队列研究。","authors":"Jayati Das-Munshi, Ioannis Bakolis, Laia Bécares, Hannah K Dasch, Jacqui Dyer, Matthew Hotopf, Rosie Hildersley, Josephine Ocloo, Robert Stewart, Ruth Stuart, Alex Dregan","doi":"10.1017/S0033291724001843","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>People with schizophrenia-spectrum and bipolar disorders (severe mental illnesses; 'SMI') experience excess mortality. Our aim was to explore longer-term trends in mortality, including the COVID-19 pandemic period, with a focus on additional vulnerabilities (psychiatric comorbidities and race/ ethnicity) in SMI.</p><p><strong>Methods: </strong>Retrospective cohort study using electronic health records from secondary mental healthcare, covering a UK region of 1.3 million people. Mortality trends spanning fourteen years, including the COVID-19 pandemic, were assessed in adults with clinician-ascribed ICD-10 diagnoses for schizophrenia-spectrum and bipolar disorders.</p><p><strong>Results: </strong>The sample comprised 22 361 people with SMI with median follow-up of 10.6 years. Standardized mortality ratios were more than double the population average pre-pandemic, increasing further during the pandemic, particularly in those with SMI and psychiatric comorbidities. Mortality risk increased steadily among people with SMI and comorbid depression, dementia, substance use disorders and anxiety over 13-years, increasing further during the pandemic. COVID-19 mortality was elevated in people with SMI and comorbid depression (sub-Hazard Ratio: 1.48 [95% CI 1.03-2.13]), dementia (sHR:1.96, 1.26-3.04) and learning disabilities (sHR:2.30, 1.30-4.06), compared to people with only SMI. COVID-19 mortality risk was similar for minority ethnic groups and White British people with SMI. Elevated all-cause mortality was evident in Black Caribbean (adjusted Rate Ratio: 1.40, 1.11-1.77) and Black African people with SMI (aRR: 1.59, 1.07-2.37) during the pandemic relative to earlier years.</p><p><strong>Conclusions: </strong>Mortality has increased over time in people with SMI. The pandemic exacerbated pre-existing trends. Actionable solutions are needed which address wider social determinants and address disease silos.</p>","PeriodicalId":20891,"journal":{"name":"Psychological Medicine","volume":" ","pages":"1-11"},"PeriodicalIF":5.9000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536139/pdf/","citationCount":"0","resultStr":"{\"title\":\"Long term mortality trends in people with severe mental illnesses and how COVID-19, ethnicity and other chronic mental health comorbidities contributed: a retrospective cohort study.\",\"authors\":\"Jayati Das-Munshi, Ioannis Bakolis, Laia Bécares, Hannah K Dasch, Jacqui Dyer, Matthew Hotopf, Rosie Hildersley, Josephine Ocloo, Robert Stewart, Ruth Stuart, Alex Dregan\",\"doi\":\"10.1017/S0033291724001843\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>People with schizophrenia-spectrum and bipolar disorders (severe mental illnesses; 'SMI') experience excess mortality. Our aim was to explore longer-term trends in mortality, including the COVID-19 pandemic period, with a focus on additional vulnerabilities (psychiatric comorbidities and race/ ethnicity) in SMI.</p><p><strong>Methods: </strong>Retrospective cohort study using electronic health records from secondary mental healthcare, covering a UK region of 1.3 million people. Mortality trends spanning fourteen years, including the COVID-19 pandemic, were assessed in adults with clinician-ascribed ICD-10 diagnoses for schizophrenia-spectrum and bipolar disorders.</p><p><strong>Results: </strong>The sample comprised 22 361 people with SMI with median follow-up of 10.6 years. Standardized mortality ratios were more than double the population average pre-pandemic, increasing further during the pandemic, particularly in those with SMI and psychiatric comorbidities. Mortality risk increased steadily among people with SMI and comorbid depression, dementia, substance use disorders and anxiety over 13-years, increasing further during the pandemic. COVID-19 mortality was elevated in people with SMI and comorbid depression (sub-Hazard Ratio: 1.48 [95% CI 1.03-2.13]), dementia (sHR:1.96, 1.26-3.04) and learning disabilities (sHR:2.30, 1.30-4.06), compared to people with only SMI. COVID-19 mortality risk was similar for minority ethnic groups and White British people with SMI. Elevated all-cause mortality was evident in Black Caribbean (adjusted Rate Ratio: 1.40, 1.11-1.77) and Black African people with SMI (aRR: 1.59, 1.07-2.37) during the pandemic relative to earlier years.</p><p><strong>Conclusions: </strong>Mortality has increased over time in people with SMI. The pandemic exacerbated pre-existing trends. Actionable solutions are needed which address wider social determinants and address disease silos.</p>\",\"PeriodicalId\":20891,\"journal\":{\"name\":\"Psychological Medicine\",\"volume\":\" \",\"pages\":\"1-11\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2024-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536139/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychological Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1017/S0033291724001843\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychological Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0033291724001843","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景:精神分裂症谱系障碍和躁郁症患者(严重精神疾病;"SMI")的死亡率过高。我们的目的是探讨死亡率的长期趋势,包括 COVID-19 大流行期间的情况,重点关注 SMI 患者的其他脆弱性(精神病合并症和种族/民族):方法:使用二级精神医疗机构的电子健康记录进行回顾性队列研究,覆盖英国一个拥有 130 万人的地区。评估了临床医生描述的 ICD-10 诊断为精神分裂症和双相情感障碍的成年人在包括 COVID-19 大流行在内的 14 年间的死亡率趋势:样本包括 22 361 名精神分裂症患者,中位随访时间为 10.6 年。标准化死亡率是大流行前人口平均死亡率的两倍多,在大流行期间进一步上升,尤其是那些患有 SMI 和精神疾病合并症的人。在 13 年的时间里,患有 SMI 和合并抑郁症、痴呆症、药物使用障碍和焦虑症的人群的死亡风险稳步上升,在大流行期间进一步上升。与仅患有 SMI 的人群相比,患有 SMI 并合并抑郁症(次危险比:1.48 [95% CI 1.03-2.13])、痴呆症(次危险比:1.96,1.26-3.04)和学习障碍(次危险比:2.30,1.30-4.06)的人群 COVID-19 死亡率较高。COVID-19 死亡率风险在少数族裔群体和英国白人 SMI 患者中相似。与早些年相比,大流行期间患有 SMI 的加勒比海黑人(调整后比率比:1.40,1.11-1.77)和非洲黑人(调整后比率比:1.59,1.07-2.37)的全因死亡率明显升高:结论:随着时间的推移,SMI 患者的死亡率有所上升。大流行加剧了原有的趋势。需要采取可行的解决方案,解决更广泛的社会决定因素和疾病孤岛问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Long term mortality trends in people with severe mental illnesses and how COVID-19, ethnicity and other chronic mental health comorbidities contributed: a retrospective cohort study.

Background: People with schizophrenia-spectrum and bipolar disorders (severe mental illnesses; 'SMI') experience excess mortality. Our aim was to explore longer-term trends in mortality, including the COVID-19 pandemic period, with a focus on additional vulnerabilities (psychiatric comorbidities and race/ ethnicity) in SMI.

Methods: Retrospective cohort study using electronic health records from secondary mental healthcare, covering a UK region of 1.3 million people. Mortality trends spanning fourteen years, including the COVID-19 pandemic, were assessed in adults with clinician-ascribed ICD-10 diagnoses for schizophrenia-spectrum and bipolar disorders.

Results: The sample comprised 22 361 people with SMI with median follow-up of 10.6 years. Standardized mortality ratios were more than double the population average pre-pandemic, increasing further during the pandemic, particularly in those with SMI and psychiatric comorbidities. Mortality risk increased steadily among people with SMI and comorbid depression, dementia, substance use disorders and anxiety over 13-years, increasing further during the pandemic. COVID-19 mortality was elevated in people with SMI and comorbid depression (sub-Hazard Ratio: 1.48 [95% CI 1.03-2.13]), dementia (sHR:1.96, 1.26-3.04) and learning disabilities (sHR:2.30, 1.30-4.06), compared to people with only SMI. COVID-19 mortality risk was similar for minority ethnic groups and White British people with SMI. Elevated all-cause mortality was evident in Black Caribbean (adjusted Rate Ratio: 1.40, 1.11-1.77) and Black African people with SMI (aRR: 1.59, 1.07-2.37) during the pandemic relative to earlier years.

Conclusions: Mortality has increased over time in people with SMI. The pandemic exacerbated pre-existing trends. Actionable solutions are needed which address wider social determinants and address disease silos.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Psychological Medicine
Psychological Medicine 医学-精神病学
CiteScore
11.30
自引率
4.30%
发文量
711
审稿时长
3-6 weeks
期刊介绍: Now in its fifth decade of publication, Psychological Medicine is a leading international journal in the fields of psychiatry, related aspects of psychology and basic sciences. From 2014, there are 16 issues a year, each featuring original articles reporting key research being undertaken worldwide, together with shorter editorials by distinguished scholars and an important book review section. The journal''s success is clearly demonstrated by a consistently high impact factor.
期刊最新文献
Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports. Charting brain GABA and glutamate levels across psychiatric disorders by quantitative analysis of 121 1H-MRS studies. Examining the mental health trajectories of children and adolescents: a cross-cohort analysis. Co-occurrence between mental disorders and physical diseases: a study of nationwide primary-care medical records. Association of cardiovascular-kidney-metabolic health and social connection with the risk of depression and anxiety.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1